Transgene Expression after Rep-Mediated Site-Specific Integration into Chromosome 19

Human Gene Therapy

Volumn 15, Issue 1, 2004, Pages 47-61

  Philpott, Nicola J ^a   Gomos, Janette ^a   Falck Pedersen, Erik ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; DNA; GREEN FLUORESCENT PROTEIN; HELICASE;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; ARTICLE; CELL CLONE; CELL LINE; CHROMOSOME 19; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DRUG SELECTIVITY; EXPERIMENTAL MODEL; GENE CONSTRUCT; GENE EXPRESSION; GENETIC STABILITY; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; INVERTED TERMINAL REPEAT; PLASMID; TRANSGENE; VIRUS GENE;

CHROMOSOMES, HUMAN, PAIR 19; DEPENDOVIRUS; DNA-BINDING PROTEINS; GENE THERAPY; GENETIC VECTORS; HELA CELLS; HUMANS; PLASMIDS; REPETITIVE SEQUENCES, NUCLEIC ACID; TRANSGENES; VIRAL PROTEINS; VIRUS INTEGRATION;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE;

EID: 0742290164     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340460732454     Document Type: Article

References (57)

1. BALAGUE, C., KALLA, M., and ZHANG, W.W. (1997). Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome. J. Virol. 71, 3299-3306.
2. BERNS, K.I. (1990). Parvovirus replication. Microbiol. Rev. 54, 316-329.
3. BERNS, K.I., and LINDEN, R.M. (1995). The cryptic life style of adeno-associated virus. Bioessays 17, 237-245.
4. CARTER, B.J., ANTONI, B.A., and KLESSIG, D.F. (1992). Adeno-virus containing a deletion of the early region 2A gene allows growth of adeno-associated virus with decreased efficiency. Virology 191, 473-476.
5. CHEUNG, A.K., HOGGAN, M.D., HAUSWIRTH, W.W., and BERNS, K.I. (1980). Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells. J. Virol. 33, 739-748.
6. CHIORINI, J.A., WENDTNER, C.M., URCELAY, E., SAFER, B., HALLEK, M., and KOTIN, R.M. (1995). High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors. Hum. Gene Ther. 6, 1531-1541.
7. DYALL, J., and BERNS, K.I. (1998). Site-specific integration of adeno-associated virus into an episome with the target locus via a deletion-substitution mechanism. J. Virol. 72, 6195-6198.
8. DYALL, J., SZABO, P., and BERNS, K.I. (1999). Adeno-associated virus (AAV) site-specific integration: Formation of AAV-AAVS1 junctions in an in vitro system. Proc. Natl. Acad. Sci. U.S.A. 96, 12849-12854.
9. GIRAUD, C., WINOCOUR, E., and BERNS, K.I. (1994). Site-specific integration by adeno-associated virus is directed by a cellular DNA sequence. Proc. Natl. Acad. Sci. U.S.A. 91, 10039-10043.
10. GIRAUD, C., WINOCOUR, E., and BERNS, K.I. (1995). Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome. J. Virol. 69, 6917-6924.
11. HANDA, H., SHIROKI, K., and SHIMOJO, H. (1977). Helper factor(s) for growth of adeno-associated virus in cells transformed by adenovirus 12. Proc. Natl. Acad. Sci. U.S.A. 74, 4508-4510.
12. HAUSWIRTH, W.W., and BERNS, K.I. (1977). Origin and termination of adeno-associated virus DNA replication. Virology 78, 488-499.
13. HERMONAT, P.L., LABOW, M.A., WRIGHT, R., BERNS, K.I., and MUZYCZKA, N. (1984). Genetics of adeno-associated virus: Isolation and preliminary characterization of adeno-associated virus type 2 mutants. J. Virol. 51, 329-339.
14. IM, D.S., and MUZYCZKA, N. (1990). The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity. Cell 61, 447-457.
15. JANIK, J.E., HUSTON, M.M., and ROSE, J.A. (1981). Locations of adenovirus genes required for the replication of adenovirus-associated virus. Proc. Natl. Acad. Sci. U.S.A. 78, 1925-1929.
16. KASS-EISLER, A., LEINWAND, L., GALL, J., BLOOM, B., and FALCK-PEDERSEN, E. (1996). Circumventing the immune response to adenovirus-mediated gene therapy. Gene Ther. 3, 154-162.
17. KEARNS, W.G., AFIONE, S.A., FULMER, S.B., PANG, M.C., ERIKSON, D., EGAN, M., LANDRUM, M.J., FLOTTE, T.R., and CUTTING, G.R. (1996). Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther. 3, 748-755.
18. KOTIN, R.M. (1994). Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum. Gene Ther. 5, 793-801.
19. KOTIN, R.M., and BERNS, K.I. (1989). Organization of adeno-associated virus DNA in latently infected Detroit 6 cells. Virology 170, 460-467.
20. KOTIN, R.M., SINISCALCO, M., SAMULSKI, R.J., ZHU, X.D., HUNTER, L., LAUGHLIN, C.A., MCLAUGHLIN, S., MUZYCZKA, N., ROCCHI, M., and BERNS, K.I. (1990). Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. U.S.A. 87, 2211-2215.
21. KOTIN, R.M., MENNINGER, J.C., WARD, D.C., and BERNS, K.I. (1991). Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter. Genomics 10, 831-834.
22. KOTIN, R.M., LINDEN, R.M., and BERNS, K.I. (1992). Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J. 11, 5071-5078.
23. LAMARTINA, S., ROSCILLI, G., RINAUDO, D., DELMASTRO, P., and TONIATTI, C. (1998). Lipofection of purified adeno-associated virus Rep68 protein: Toward a chromosome-targeting nonviral particle. J. Virol. 72, 7653-7658.
24. LAMARTINA, S., SPORENO, E., FATTORI, E., and TONIATTI, C. (2000). Characteristics of the adeno-associated virus preintegration site in human chromosome 19: Open chromatin conformation and transcription-competent environment. J. Virol. 74, 7671-7677.
25. LINDEN, R.M., WARD, P., GIRAUD, C., WINOCOUR, E., and BERNS, K.I. (1996a). Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. U.S.A. 93, 11288-11294.
26. LINDEN, R.M., WINOCOUR, E., and BERNS, K.I. (1996b). The recombination signals for adeno-associated virus site-specific integration. Proc. Natl. Acad. Sci. U.S.A. 93, 7966-7972.
27. LUSBY, E., FIFE, K.H., and BERNS, K.I. (1980). Nucleotide sequence of the inverted terminal repetition in adeno-associated virus DNA. J. Virol. 34, 402-409.
28. MILLER, S.A., DYKES, D.D., and POLESKY, H.F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215.
29. NI, T.H., ZHOU, X., McCARTY, D.M., ZOLOTUKHIN, I., and MUZYCZKA, N. (1994). In vitro replication of adeno-associated virus DNA. J. Virol. 68, 1128-1138.
30. NONY, P., TESSIER, J., CHADEUF, G., WARD, P., GIRAUD, A., DUGAST, M., LINDEN, R.M., MOULLIER, P., and SALVETTI, A. (2001). Novel cis-acting replication element in the adeno-associated virus type 2 genome is involved in amplification of integrated rep-cap sequences. J. Virol. 75, 9991-9994.
31. OWENS, R.A. (2002). Second generation adeno-associated virus type 2-based gene therapy systems with the potential for preferential integration into AAVS1. Curr. Gene Ther. 2, 145-159.
32. PHILPOTT, N.J., GIRAUD-WALI, C., DUPUIS, C., GOMOS, J., HAMILTON, H., BERNS, K.I., and FALCK-PEDERSEN, E. (2002a). Efficient integration of recombinant adeno-associated virus DNA vectors requires a p5-rep sequence in cis. J. Virol. 76, 5411-5421.
33. PHILPOTT, N.J., GOMOS, J., BERNS, K.I., and FALCK-PEDERSEN, E. (2002b). A p5 integration efficiency element mediates Rep-dependent integration into AAVS1 at chromosome 19. Proc. Natl. Acad. Sci. U.S.A. 99, 12381-12385.
34. SAMULSKI, R.J., SRIVASTAVA, A., BERNS, K.I., and MUZYCZKA, N. (1983). Rescue of adeno-associated virus from recombinant plasmids: Gene correction within the terminal repeats of AAV. Cell 33, 135-143.
35. SAMULSKl, R.J., ZHU, X., XIAO, X., BROOK, J.D., HOUSMAN, D.E., EPSTEIN, N., and HUNTER, L.A. (1991). Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 10, 3941-3950.
36. SENAPATHY, P., and CARTER, B.J. (1984). Molecular cloning of adeno-associated virus variant genomes and generation of infectious virus by recombination in mammalian cells. J. Biol. Chem. 259, 4661-4666.
37. SNYDER, R.O., IM, D.S., and MUZYCZKA, N. (1990). Evidence for covalent attachment of the adeno-associated virus (AAV) Rep protein to the ends of the AAV genome. J. Virol. 64, 6204-6213.
38. SNYDER, R.O., IM, D.S., NI, T., XIAO, X., SAMULSKI, R.J., and MUZYCZKA, N. (1993). Features of the adeno-associated virus origin involved in substrate recognition by the viral Rep protein. J. Virol. 67, 6096-6104.
39. SRIVASTAVA, A. (1987). Replication of the adeno-associated virus DNA termini in vitro. Intervirology 27, 138-147.
40. SRIVASTAVA, A., LUSBY, E.W., and BERNS, K.I. (1983). Nucleotide sequence and organization of the adeno-associated virus 2 genome. J. Virol. 45, 555-564.
41. STRAUS, S.E., GINSBERG, H.S., and ROSE, J.A. (1975). DNA-minus temperature-sensitive mutants of adenovirus type 5 help adeno-virus-associated virus replication. J. Virol. 17, 140-148.
42. SUROSKY, R.T., URABE, M., GODWIN, S.G., MCQUISTON, S.A., KURTZMAN, G.J., OZAWA, K., and NATSOULIS, G. (1997). Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J. Virol. 71, 7951-7959.
43. TRATSCHIN, J.D., MILLER, I.L., and CARTER, B.J. (1984). Genetic analysis of adeno-associated virus: Properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function. J. Virol. 51, 611-619.
44. TSUNODA, H., HAYAKAWA, T., SAKURAGAWA, N., and KOYAMA, H. (2000). Site-specific integration of adeno-associated virus-based plasmid vectors in lipofected HeLa cells. Virology 268, 391-401.
45. TULLIS, G.E., and SHENK, T. (2000). Efficient replication of adeno-associated virus type 2 vectors: A cis-acting element outside of the terminal repeats and a minimal size. J. Virol. 74, 11511-11521.
46. URCELAY, E., WARD, P., WIENER, S.M., SAFER, B., and KOTIN, R.M. (1995). Asymmetric replication in vitro from a human sequence element is dependent on adeno-associated virus Rep protein. J. Virol. 69, 2038-2046.
47. WALSH, C.E., LIU, J.M., XIAO, X., YOUNG, N.S., NIENHUIS, A.W., and SAMULSKI, R.J. (1992). Regulated high level expression of a human γ-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc. Natl. Acad. Sci. U.S.A. 89, 7257-7261.
48. WANG, X.S., and SRIVASTAVA, A. (1997). A novel terminal resolution-like site in the adeno-associated virus type 2 genome. J. Virol. 71, 1140-1146.
49. WEITZMAN, M.D., KYOSTIO, S.R., KOTIN, R.M., and OWENS, R.A. (1994). Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc. Natl. Acad. Sci. U.S.A. 91, 5808-5812.
50. WU, J., DAVIS, M.D., and OWENS, R.A. (2001). A Rep recognition sequence is necessary but not sufficient for nicking of DNA by adeno-associated virus type-2 Rep proteins. Arch. Biochem. Biophys. 389, 271-277.
51. XIAO, X., LI, J., and SAMULSKI, R.J. (1996). Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70, 8098-8108.
52. YAKINOGLU, A.O., HEILBRONN, R., BURKLE, A., SCHLEHOFER, J.R., and ZUR HAUSEN, H. (1988). DNA amplification of adeno-associated virus as a response to cellular genotoxic stress. Cancer Res. 48, 3123-3129.
53. YAKOBSON, B., KOCH, T., and WINOCOUR, E. (1987). Replication of adeno-associated virus in synchronized cells without the addition of a helper virus. J. Virol. 61, 972-981.
54. YANG, C.C., XIAO, X., ZHU, X., ANSARDI, D.C., EPSTEIN, N.D., FREY, M.R., MATERA, A.G., and SAMULSKI, R.J. (1997). Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro. J. Virol. 71, 9231-9247.
55. YOUNG, S.M., JR., and SAMULSKI, R.J. (2001). Adeno-associated virus (AAV) site-specific recombination does not require a Rep-dependent origin of replication within the AAV terminal repeat. Proc. Natl. Acad. Sci. U.S.A. 98, 13525-13530.
56. YOUNG, S.M., JR., McCARTY, D.M., DEGTYAREVA, N., and SAMULSKI, R.J. (2000). Roles of adeno-associated virus Rep protein and human chromosome 19 in site-specific recombination. J. Virol. 74, 3953-3966.
57. ZOLOTUKHIN, S., POTTER, M., HAUSWIRTH, W.W., GUY, J., and MUZYCZKA, N. (1996). A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J. Virol. 70, 4646-4654.